fig5
Figure 5. Longitudinal biomarker follow-up of Fabry gene therapy trial participant #2.
Rare Disease and Orphan Drugs Journal
ISSN 2771-2893 (Online)
Navigation
Navigation
Committee on Publication Ethics
https://members.publicationethics.org/members/rare-disease-and-orphan-drugs-journal
Portico
All published articles are preserved here permanently:
https://www.portico.org/publishers/oae/
Committee on Publication Ethics
https://members.publicationethics.org/members/rare-disease-and-orphan-drugs-journal Portico
All published articles are preserved here permanently:
https://www.portico.org/publishers/oae/